# Scandinavian Cystic Fibrosis Azithromycin Study

> **NCT00411736** · PHASE4 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 45 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Study medication, azithromycin or placebo
- **DRUG:** Azithromycin or placebo tablets

## Key facts

- **NCT ID:** NCT00411736
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2013-12
- **Final completion:** 2014-03
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2014-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00411736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00411736, "Scandinavian Cystic Fibrosis Azithromycin Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00411736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*